Cargando…
Myotonic Dystrophy—A Progeroid Disease?
Myotonic dystrophies (DM) are slowly progressing multisystemic disorders caused by repeat expansions in the DMPK or CNBP genes. The multisystemic involvement in DM patients often reflects the appearance of accelerated aging. This is partly due to visible features such as cataracts, muscle weakness,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095001/ https://www.ncbi.nlm.nih.gov/pubmed/30140252 http://dx.doi.org/10.3389/fneur.2018.00601 |
_version_ | 1783347903608127488 |
---|---|
author | Meinke, Peter Hintze, Stefan Limmer, Sarah Schoser, Benedikt |
author_facet | Meinke, Peter Hintze, Stefan Limmer, Sarah Schoser, Benedikt |
author_sort | Meinke, Peter |
collection | PubMed |
description | Myotonic dystrophies (DM) are slowly progressing multisystemic disorders caused by repeat expansions in the DMPK or CNBP genes. The multisystemic involvement in DM patients often reflects the appearance of accelerated aging. This is partly due to visible features such as cataracts, muscle weakness, and frontal baldness, but there are also less obvious features like cardiac arrhythmia, diabetes or hypogammaglobulinemia. These aging features suggest the hypothesis that DM could be a segmental progeroid disease. To identify the molecular cause of this characteristic appearance of accelerated aging we compare clinical features of DM to “typical” segmental progeroid disorders caused by mutations in DNA repair or nuclear envelope proteins. Furthermore, we characterize if this premature aging effect is also reflected on the cellular level in DM and investigate overlaps with “classical” progeroid disorders. To investigate the molecular similarities at the cellular level we use primary DM and control cell lines. This analysis reveals many similarities to progeroid syndromes linked to the nuclear envelope. Our comparison on both clinical and molecular levels argues for qualification of DM as a segmental progeroid disorder. |
format | Online Article Text |
id | pubmed-6095001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60950012018-08-23 Myotonic Dystrophy—A Progeroid Disease? Meinke, Peter Hintze, Stefan Limmer, Sarah Schoser, Benedikt Front Neurol Neurology Myotonic dystrophies (DM) are slowly progressing multisystemic disorders caused by repeat expansions in the DMPK or CNBP genes. The multisystemic involvement in DM patients often reflects the appearance of accelerated aging. This is partly due to visible features such as cataracts, muscle weakness, and frontal baldness, but there are also less obvious features like cardiac arrhythmia, diabetes or hypogammaglobulinemia. These aging features suggest the hypothesis that DM could be a segmental progeroid disease. To identify the molecular cause of this characteristic appearance of accelerated aging we compare clinical features of DM to “typical” segmental progeroid disorders caused by mutations in DNA repair or nuclear envelope proteins. Furthermore, we characterize if this premature aging effect is also reflected on the cellular level in DM and investigate overlaps with “classical” progeroid disorders. To investigate the molecular similarities at the cellular level we use primary DM and control cell lines. This analysis reveals many similarities to progeroid syndromes linked to the nuclear envelope. Our comparison on both clinical and molecular levels argues for qualification of DM as a segmental progeroid disorder. Frontiers Media S.A. 2018-07-25 /pmc/articles/PMC6095001/ /pubmed/30140252 http://dx.doi.org/10.3389/fneur.2018.00601 Text en Copyright © 2018 Meinke, Hintze, Limmer and Schoser. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Meinke, Peter Hintze, Stefan Limmer, Sarah Schoser, Benedikt Myotonic Dystrophy—A Progeroid Disease? |
title | Myotonic Dystrophy—A Progeroid Disease? |
title_full | Myotonic Dystrophy—A Progeroid Disease? |
title_fullStr | Myotonic Dystrophy—A Progeroid Disease? |
title_full_unstemmed | Myotonic Dystrophy—A Progeroid Disease? |
title_short | Myotonic Dystrophy—A Progeroid Disease? |
title_sort | myotonic dystrophy—a progeroid disease? |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095001/ https://www.ncbi.nlm.nih.gov/pubmed/30140252 http://dx.doi.org/10.3389/fneur.2018.00601 |
work_keys_str_mv | AT meinkepeter myotonicdystrophyaprogeroiddisease AT hintzestefan myotonicdystrophyaprogeroiddisease AT limmersarah myotonicdystrophyaprogeroiddisease AT schoserbenedikt myotonicdystrophyaprogeroiddisease |